Management of elevated prostate-specific antigen in men with nonbacterial chronic prostatitis

Current Urology Reports

Volumn 10, Issue 4, 2009, Pages 302-306

  Sandhu, Jaspreet S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; PROSTATE SPECIFIC ANTIGEN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SCREENING; CHRONIC PROSTATITIS; CLINICAL PRACTICE; DISEASE CLASSIFICATION; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ORGANIZATION; HUMAN; LABORATORY DIAGNOSIS; LOWER URINARY TRACT SYMPTOM; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVIEW; SCREENING; UNITED STATES;

CHRONIC DISEASE; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATITIS;

EID: 68149168567     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-009-0049-0     Document Type: Review

References (27)

1. R.J. Albin W.A. Soanes P. Bronson E. Witebsky 1970 Precipitating antigens of the normal human prostate J Reprod Fertil 22 573 574
2. M. Kuriyama M.C. Wang L.D. Papsidero 1980 Quantification of prostate specific antigen in serum by a sensitive enzyme immunoassay Cancer Res 40 4658 4662 (Pubitemid 11199734)
3. H. Lilja 1985 A kallikrein-like serum protease in prostatic fluid cleaves the predominant seminal vesicle protein J Clin Invest 76 1899 1903 (Pubitemid 16196061)
4. H. Lilja J. Oldbring G. Rannevik C.B. Laurell 1987 Seminalsecreted proteins and their reactions during gelation and liquefaction of human semen J Clin Invest 80 281 285
5. H. Lilja 1993 Significance of different molecular forms of serum PSA: the free, noncomplexed form of PSA versus that complexed to alpha-1- antichymotrypsin Urol Clin North Am 20 681 686 (Pubitemid 24141161)
6. W.J. Catalona A.W. Partin K.M. Slawin 1998 A multicenter clinical trial evaluation of free PSA in the differentiation of prostate cancer from benign disease JAMA 279 1542 1547
7. R. Lieberman 2004 Evidence-based medical perspectives: the evolving role of PSA for early detection, monitoring of treatment response, and as a surrogate end point of efficacy for interventions in men with different clinical risk states for the prevention and progression of prostate cancer Am J Ther 11 501 506
8. J.E. Oesterling S.J. Jacobsen C.G. Chute 1993 Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges JAMA 270 860 864 (Pubitemid 23234116)
9. J. Morote M. Lopez G. Encabo I.M. de Torres 2000 Effect of inflammation and benign prostatic enlargement on total and free serum prostate specific antigen Eur Urol 37 537 540 (Pubitemid 30189821)
10. D.K. Ornstein D.S. Smith P.A. Humphrey W.J. Catalona 1998 The effect of prostate volume, age, total prostate specific antigen level and acute inflammation on the percent free serum prostate specific antigen levels in men without clinically detectable prostate cancer J Urol 159 1234 1237 (Pubitemid 28172804)
11. National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases Workshop on Chronic Prostatitis: National Institutes of Health Summary Statement. Executive Summary. Bethesda, MD; 1995.
12. J.C. Nickel L.M. Nyberg M. Hennenfent 1999 Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network Urology 54 229 233 (Pubitemid 29367243)
13. L.D. True R.E. Berger I. Rothman 1999 Prostate histopathology and chronic prostatitis/chronic pelvic pain syndrome: a prospective biopsy study J Urol 162 2014 2018
14. B.S. Carver C.B. Bozeman B.J. William D.D. Venable 2003 The prevalence of men with National Institutes of Health category IV prostatitis and association with serum prostate specific antigen J Urol 169 589 591 (Pubitemid 36132991)
15. K. Okada M. Kojima Y. Naya 2000 Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer Urology 55 892 898 (Pubitemid 30330795)
16. I. Stancik W. Luftenegger M. Klimpfinger 2004 Effect of NIH-IV prostatitis on free and free-to-total PSA Eur Urol 46 760 764 (Pubitemid 39488408)
17. W.E. Rowe M.E. Laniado M.M. Walker P. Anup 2006 Incidental acute prostatic inflammation is associated with a lower percentage of free prostate-specific antigen than other benign conditions of the prostate: a prospective screening study BJU Int 97 1039 1042
18. C.B. Bozeman B.S. Carver J.A. Eastham D.D. Venable 2002 Treatment of chronic prostatitis lowers serum prostate specific antigen J Urol 167 1723 1726 (Pubitemid 34240711)
19. J.M. Potts 2000 Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen J Urol 164 1550 1553 (Pubitemid 30781699)
20. R.B. Nadler M.M. Collins K.J. Propert 2006 Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis/chronic pelvic pain syndrome Urology 67 337 342 (Pubitemid 43189852)
21. J.A. Eastham E. Riedel P.T. Scardino 2003 Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations JAMA 289 2695 2700 (Pubitemid 37430140)
22. D.P. Ankerst R. Miyamoto P.V. Nair 2009 Yearly prostate specific antigen and digital rectal examination fluctuations in a screened population J Urol 181 2071 2075
23. S. Loeb S.N. Gashti W.J. Catalona 2009 Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA) Urol Oncol 27 64 66
24. P.T. Scardino 2007 The responsible use of antibiotics for an elevated PSA level Nat Clin Pract Urol 4 1 (Pubitemid 46062974)
25. L.V. Rodriquez M.K. Terris 1998 Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature J Urol 160 2115 2020
26. M. Aron T.P. Rajeev N.P. Gupta 2000 Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study BJU Int 85 682 685 (Pubitemid 30192834)
27. J. Feliciano E. Teper M. Ferrandino 2008 The incidence of fluoroquinolone resistant infections after prostate biopsy: are fluoroquinolones still effective prophylaxis? J Urol 179 952 955